In 2007, The Controlled Drugs (Supervision of Management and Use) Regulations 2006 were introduced as part of the Government’s response to the Shipman Inquiry’s Fourth report in 2004.
The aim of these regulations was to strengthen the governance arrangements for the use and management of controlled drugs. Controlled Drugs (CDs) are essential to modern clinical care. As such, it is essential that NHS England enforces robust arrangements for the management and use of CDs to minimise patient harm, misuse and criminality. As a consequence of passing the Health and Social Care Act 2012, the 2006 regulations have been revised to reflect the new architecture in the NHS in England. The Controlled Drugs (Supervision of Management and Use) Regulations 2013 came into force in England on 1st April 2013.
The following documents have been prepared for action and onward dissemination by Controlled Drug Accountable Officers (CDAO). As the lead for the Local Intelligence Networks (LINs), the CDAO for NHS England regional teams will wish to ensure that the relevant teams across the LIN are familiar with the standard operating model for controlled drug accountable officer function.